Publications by authors named "Michelle Esplin"

Claim this Profile
P
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up.
Anna W Chalmers, Shiven Patel, Ken Boucher, Laura Cannon, Michelle Esplin

Target Oncolยท August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis